Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
JAMA Oncology|July 21, 2017
Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast CancerV Craig Jordan
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--pointV Craig Jordan
Steroids|September 4, 2007
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancerV Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?V Craig Jordan
Endocrine-Related Cancer|March 19, 2014
'Who do you think you are?'V Craig Jordan
Endocrine-Related Cancer|March 25, 2014
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancerV Craig Jordan
Annals of Surgical Oncology|March 27, 2019
The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science LectureV Craig Jordan
Journal of the National Cancer Institute|June 12, 2008
The rise of raloxifene and the fall of invasive breast cancerV Craig Jordan
Integrative Cancer Therapies|June 9, 2016
A Raloxifene Withdrawal Response: Translational Research, Definitions, and Clinical ApplicationsV Craig Jordan
Bone|March 9, 2004
Aromatase inhibitors that regulate estrogen target tissues selectively?V Craig Jordan
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
JAMA Oncology|July 21, 2017
Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast CancerV Craig Jordan
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--pointV Craig Jordan
Steroids|September 4, 2007
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancerV Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?V Craig Jordan
Endocrine-Related Cancer|March 19, 2014
'Who do you think you are?'V Craig Jordan
Endocrine-Related Cancer|March 25, 2014
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancerV Craig Jordan
Annals of Surgical Oncology|March 27, 2019
The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science LectureV Craig Jordan
Journal of the National Cancer Institute|June 12, 2008
The rise of raloxifene and the fall of invasive breast cancerV Craig Jordan
Integrative Cancer Therapies|June 9, 2016
A Raloxifene Withdrawal Response: Translational Research, Definitions, and Clinical ApplicationsV Craig Jordan
Bone|March 9, 2004
Aromatase inhibitors that regulate estrogen target tissues selectively?V Craig Jordan
Pageof 22